Statement
|
1.Date of occurrence of the event:2024/10/30
2.Company name:Lumosa Therapeutics Co., Ltd.
3.Relationship to the Company (please enter "head office" or
"subsidiaries"):head office
4.Reciprocal shareholding ratios:not applicable
5.Cause of occurrence:
Following the Directorate-General of Personnel Administration's announcement
of office and school closures on October 31 due to Typhoon Kong-rey, Lumosa
hereby announces the adjustments to the 2024 cash capital increase schedule.
6.Countermeasures:
(1) Payment deadline for existing shareholders and employees will remain on
Monday, November 4, 2024.
(2) Public subscription deadline has been rescheduled from Thursday,
October 31, to Friday, November 1, 2024.
(3) Payment deadline for designated parties has been rescheduled from
Wednesday, November 6, to Thursday, November 7, 2024.
(4) Cash capital increase record date (payment completion date) has been
rescheduled from Thursday, November 7, to Friday, November 8, 2024.
(5) Trading commencement date for subscription payment certificates has been
rescheduled from Tuesday, November 12, to Wednesday, November 13, 2024.
7.Any other matters that need to be specified(the information
disclosure also meets the requirements of Article 7, subparagraph 9
of the Securities and Exchange Act Enforcement Rules, which brings
forth a significant impact on shareholders rights or the price of
the securities on public companies.):None
|